Adaptive Symbiotic Technologies (AST) is an American startup engaged in the development, production, and marketing of new strains of Trichoderma spp. For this company, we have investigated the marketing possibilities of these strains and we have mapped out how and with which commercial claims these strains can be admitted to the European market.
